Cardiovascular Medicine

Product Details:

Xarelto 10 is an oral anticoagulant containing Rivaroxaban Ph. Eur. 10mg, a direct Factor Xa inhibitor. It is primarily used to prevent blood clots in patients undergoing hip or knee replacement surgery and for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Rivaroxaban works by reducing the ability of the blood to clot, thereby lowering the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Uses:

• Prevention of venous thromboembolism (VTE)

• Stroke prevention in non-valvular atrial fibrillation

• Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Key Features:

• Trusted oral anticoagulant therapy

• Convenient once-daily dosing

• High bioavailability and rapid onset of action

• Clinically proven efficacy in reducing thrombotic events

Storage:
Store below 30°C. Protect from moisture and direct sunlight.

Note:
To be sold by retail on the prescription of a Registered Medical Practitioner only.

Product Details:

Xarelto 15 (Rivaroxaban Ph. Eur. 15 mg) is an oral anticoagulant used to prevent and treat blood clots. It belongs to a class of medications known as direct Factor Xa inhibitors and is commonly prescribed for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Key Features:

• Composition: Rivaroxaban Ph. Eur. 15 mg

• Form: Film-coated tablet

• Packaging: Strip/Box as per requirement

• Usage: Prescription medicine

• Administration: Oral

• Storage: Store below 30°C in a dry place, away from direct sunlight

Indications:

• Treatment of DVT and PE

• Prevention of recurrent DVT and PE

• Prevention of stroke in atrial fibrillation (non-valvular)

Manufacturer: [Mention Manufacturer Name, if required]

Note: This product should be used under the supervision of a qualified healthcare professional.

Product Details:

Xarelto 2.5 (Rivaroxaban Ph. Eur. 2.5 mg) is an oral anticoagulant used to prevent blood clots and reduce the risk of cardiovascular events in patients with a history of acute coronary syndrome (ACS) or peripheral artery disease (PAD). Rivaroxaban is a selective direct Factor Xa inhibitor, which helps prevent the formation of thrombin and thrombi in the blood.

Key Uses:

• Prevention of atherothrombotic events in adult patients with ACS or PAD

• Used alongside antiplatelet therapy such as aspirin or clopidogrel

• Helps in reducing risk of stroke, heart attack, and other clot-related conditions

Key Features:

• Clinically proven effectiveness

• Convenient once or twice daily dosing (as per indication)

• High-quality formulation as per European Pharmacopoeia standards

• Manufactured under GMP-certified facilities

Note: Use only under medical supervision. Not for self-medication.